BENTONVILLE, Ark. — As New Year wellness goals take shape, Sam’s Club is highlighting its pharmacy teams as a key resource for members exploring GLP-1 weight management therapies, including the first FDA-approved oral option.
Starting next week, Sam’s Club pharmacies will begin offering initial doses of oral Wegovy (1.5 mg) for $149 per month through the manufacturer’s self-pay program. The retailer stated that the rollout will be supported by in-store pharmacist counseling, digital wellness tools, and service-focused pharmacy programs, including free same-day pharmacy delivery for Plus members.
Company officials stated that pharmacists will play a key role in helping members understand what starting GLP-1 therapy entails in daily practice, including guidance on side effects, hydration, nutrition, and realistic expectations. Sam’s Club pharmacies have been ranked No. 1 in customer satisfaction among mass merchandiser pharmacies by J.D. Power for 10 consecutive years, a distinction the company credits to its focus on pharmacist engagement.
In addition to in-person counseling, members can access GLP-1–specific education and lifestyle resources through the Sam’s Club-exclusive version of the Well App, which offers nutrition and exercise support as well as access to an on-demand health concierge team. Sam’s Club also mentioned that pharmacists are available to provide education even for members who do not fill their prescriptions at the store.
The initiative comes as interest in medical weight management continues to grow early in the year, following approval of the first oral GLP-1 option by the U.S. Food and Drug Administration. Sam’s Club stated that its approach is designed to ensure that expanded access to GLP-1 therapies is paired with practical, service-oriented support that helps members develop sustainable health habits.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
